Avandia Recall
Avandia Recall Almost A Reality.
Even though nearly all committee members of the FDA advisory specified that Avandia side effects were life-threatening to patients, having caused heart attacks, the majority of the committee chose to allow the diabetes drug to remain in the market, however, with strict restrictions.
The United States Food and Drug Administration have made a decision with regards on the controversial diabetes drug, ordering for the drug to be prescribed under sever restrictions. At the same time, an Avandia recall was issued in Europe as per recommendation by the European drug regulators. As of April 2011, the New Zealand Ministry of Health has also issued for the withdrawal of Avandia from its market due to same reasons.
Today, the use of Avandia is strictly not allowed in the United States, however not absolutely. Under circumstances that other medications are unable to control the disease, patients with Type 2 diabetes have the option to use Avandia under the order of their doctor.
Due to this restriction, the pharmaceutical company producing Avandia, GlaxoSmithKline, developed a risk evaluation and mitigation strategy (REMS) that prevents anyone from acquiring the drug without the significant needs. Almost works as an Avandia recall.
Full Avandia Recall Should Come In USA
On July 2010, the FDA stopped the clinical trial TIDE being conducted by Glaxo. The trial involved comparing the health benefits of Avandia versus other competing drug, such Actos produced by Takeda Pharmaceuticals. These trials were being performed around the globe, having farmed test subjects from third world countries since people there would mostly be unaware of the drug’s effect. The halt of the trial was also due to it being unethical, as critics said, to enrolled test subjects, as these people may be exposed to known fatal drug complications. Recently, India had declared that it will be banning GlaxoSmithKline from recruiting people in the country. According to a newer study published in the British Medical Journal on March of 2011, Avandia does pose a higher risk of heart attack congestive heart failure and death compared to Actos. This study helped confirm the findings of studies done in the years past.Patients who used Avandia had significantly higher chances of experiencing heart problems than patients who used Actos according to the results. It suggests that for every 100 thousand clients taking Avandia, there would be around 170 more heart attacks, 649 more congestive heart failures and 431 more deaths. Avandia Recall is a must.
Unlike the United States, the European Medicines Agency placed full ban on the availability of Avandia in the European countries, having issued for a Avandia recall.
These recommendations were only decided, and made official, after having three years of detailed debates involving conflicting research data which pitted FDA staff and independent researchers. The debate argued whether or not the drug Avandia truly posed a threat to patients in regards to cardiovascular problems. While some accepted the decisions, others were disappointed for not having a complete ban or recall of the drug.
“Allowing Avandia to remain on the market, but under restrictions, is an appropriate response, given the significant safety concerns and the scientific uncertainty still remaining about this drug,” said Dr. Janet Woodcock, director of the FDA Center for Drug Evaluation and Research.
“Avandia may not be right for every single patient, but it certainly is an important medicine that should be available to patients,” said Jai Patel, the company’s vice president in metabolic clinical research, in July of 2010. “When your disease progresses and other agents don’t work, the long-term durable effect will potentially be useful in that patient population,” he added.
No Avandia Recall Responsible for 100 thousand heart problems
The former best-selling diabetes drug has now become a favorite issue to criticize by numerous experts, including some FDA drug safety reviewers, who have projected that more than 100 thousand heart problems and mortalities were caused by Avandia since its approval into the market.
Experts say that using alternative medications would be a lot safer and better than having to risk the health of the patient, whose health is already diminished due to the illness of diabetes.
Still, even if no Avandia recall was ordered, many people, common and experts alike, think that the drug is already dead, and sales of it will plummet even more because of the magnitude of injuries and controversies it had led. Many believe that doctors will be hesitant to even entertain the drug due to high health risks. Although the advisory committee rejected the idea of recalling Avandia, the FDA still could have chosen to ban Avandia for the welfare and protection of consumers.
The pharmaceutical company responsible for this mess has faced more than 13 thousand lawsuits filed by plaintiffs who say that GlaxoSmithKline was irresponsible with its information dissemination and thus caused avoidable damage to countless lives. In the summer of 2010, Glaxo announced that it had accomplished Avandia settlements in around 10 thousand of the suits that filed against them. Earlier in 2011, Glaxo made an agreement to pay more than $700 million to settle more Avandia lawsuit claims. After many settlements, Glaxo has said that it no longer promote the drug.
Avandia Recall is a must before more avandia victims are put in danger.